Search Site

Edward D. Huey, MD

  • Assistant Professor of Psychiatry
  • Assistant Professor of Neurology (in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain)
Edward D. Huey, MD

Edward (Ted) Huey, M.D. is an Assistant Professor of Psychiatry and Neurology at Columbia University College of Physicians and Surgeons (New York, NY), in the Departments of Psychiatry (Division of Geriatric Psychiatry) and Neurology (Division of Aging and Dementia), the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, and the Gertrude H. Sergievsky Center.

Dr. Huey obtained his B.A. in psychology from Yale University. He received his medical degree from the Stanford University School of Medicine in 1999. He completed an internship and a residency in Adult Psychiatry at the Stanford University Medical Center in Stanford, California. He was elected to be the chief resident for the program in his final year of residency. He then completed a clinical research fellowship and was an Assistant Clinical Investigator in the Cognitive Neuroscience Section of the National Institute of Neurological Disorders and Stroke in the National Institutes of Health in Bethesda, MD. He was then the Director of Clinical Science of the Litwin-Zucker Research Center for the Study of Alzheimer's Disease and Memory Disorders of the Feinstein Institute, North-Shore / Long Island Jewish Medical Center. He joined the Columbia University faculty in 2010.

Dr. Huey is interested in the interface between psychiatry and neurology -- the behavioral, cognitive and emotional effects of neurological disorders and what we can learn about psychiatric disorders from patients with neuroanatomic and genetic disorders.

Dr. Huey's research has focused on patients with frontal lobe disorders, including patients with frontotemporal lobar degeneration (FTLD) and related disorders such as corticobasal syndrome and ALS, and brain injury. He studies the genetics of FTLD and is interested in the range of behavioral and emotional symptoms associated with mutations that cause FTLD. He also uses imaging in patients with frontal lobe disorders to explore the role of the frontal lobes in behavior and emotion, and the development of psychiatric disorders including mood disorders, PTSD, and OCD. A third interest is in the role of the dopamine system in the pathogenesis and treatment of the symptoms of FTLD. He is the recipient of a NIH / NINDS Pathway to Independence Award to research novel medication treatments and imaging biomarkers for FTLD. 

Departmental Appointments

  • Department of Neurology
    Division of Aging and Dementia
  • Department of Psychiatry
    Division of Geriatric Psychiatry

Education & Training

  • Stanford University School of Medicine
  • Residency: Stanford University Medical Center
  • Fellowship: National Institute of Mental Health

Centers/Institutes/Programs

  • Taub Institute for Research on Alzheimer's Disease and the Aging Brain

Research Interests

  • Behavioral, cognitive and emotional effects of neurological disorders
  • frontotemporal dementia
  • FTD
  • FTLD
  • Huntington's disease
  • HD
  • Pick's disease
  • Frontotemporal lobar degeneration
  • Progressive Supranuclear Palsy
  • PSP
  • Corticobasal syndrome
  • CBS
  • Corticobasal ganglionic degeneration
  • CBD
  • CBGD
  • Neuropsychiatry

NIH Grants

  • PREDICTORS OF SEVERITY IN ALZHEIMER S DISEASE (Federal Gov)

    Jun 15 2017 - May 31 2022

    EXPLORING COGNITIVE AGING USING REFERENCE ABILITY NEURAL NETWORKS (Federal Gov)

    Aug 1 2016 - Jun 30 2021

    LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) (Federal Gov)

    Sep 30 2014 - May 31 2019

    CLINICAL-PATHOLOGICAL STUDY OF COGNITIVE IMPAIRMENT IN ESSENTIAL TREMOR (Federal Gov)

    Jun 1 2014 - May 31 2019

    EXAMINATION OF THE EARLIEST SYMPTOMS AND BIOMARKERS OF FTLD MAPT CARRIERS (Federal Gov)

    Sep 21 2012 - Jul 31 2018

    OLFACTORY DEFICITS AND DONEPEZIL TREATMENT IN COGNITIVELY IMPAIRED ELDERLY (Federal Gov)

    Jun 15 2013 - May 31 2018

    LOW-DOSE LITHIUM FOR THE TREATMENT OF BEHAVIORAL SYMPTOMS IN FTD (Private)

    Apr 1 2016 - Mar 31 2017

    CLINICAL-PATHOLOGICAL STUDY OF COGNITIVE IMPAIRMENT IN ESSENTIAL TREMOR (Federal Gov)

    Jul 1 2015 - May 31 2016

    BDNF VAL66MET GENOTYPE AND AGE: IMPACT ON BIOMARKERS AND EXERCISE-BASED TREATMENT (Federal Gov)

    Sep 15 2011 - May 31 2016

    THE FRONTOTEMPORAL LOBAR DEGENERATION CLINICAL RESEARCH CONSORTIUM (Federal Gov)

    Oct 1 2014 - Jul 31 2015

    INVESTIGATION OF THE DOPAMINE SYSTEM IN FRONTOTEMPORAL DEMENTIA (Federal Gov)

    May 1 2009 - Apr 30 2014

Publications

  • Huey ED, Goveia EN, Paviol S, Pardini M, Krueger F, Zamboni G, Tierney MC, Wassermann EM, Grafman J: Executive dysfunction in frontotemporal dementia and corticobasal syndrome.& Neurology 2009;72(5): 453-9
  • Huey ED, Pardini M, Cavanagh A, Wassermann EM, Kapogiannis D, Spina S, Ghetti B, Grafman J: Ideomotor apraxia is associated with frontal grey matter volume loss in corticobasal syndrome. Archives of Neurology 2009;66(10): 1274-80
  • Koenigs M, Huey ED, Raymont V, Cheon B, Solomon J, Wassermann EM, Grafman, J: Focal brain damage protects against post-traumatic stress disorder in combat veterans. Nature Neuroscience 2008;11: 232-7
  • Huey ED, Grafman J, Wassermann EM, Pietrini P, Tierney MC, Ghetti B, Spina S, Baker M, Hutton M, Elder JW, Berger SL, Heflin KA, Hardy J, Momeni P: Characteristics of frontotemporal dementia patients with a Progranulin mutation. Annals of Neurology 2006;60(3): 374-380
  • Huey ED, Zahn R, Krueger F, Moll J, Kapogiannis D, Wassermann EM, Grafman J: A psychological and neuroanatomical model of obsessive-compulsive disorder. Journal of Neuropsychiatry and Clinical Neurosciences 2008;Nov: 390-408

For a complete list of publications, please visit PubMed.gov